reviewNature Reviews Drug DiscoveryAug 1, 2006Closed access

Current development of mTOR inhibitors as anticancer agents

SFSandrine FaivreGKGuido KroemerÉRÉric Raymond

Hôpital Beaujon · Institut Gustave Roussy · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

993
total citations
FWCI
26.44
Percentile
100%
References
179
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • PI3K/AKT/mTOR pathway
  • Discovery and development of mTOR inhibitors
  • Anabolism
  • Medicine
  • Clinical trial
  • Anticancer drug
  • Kinase
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.